Cubeddu LX - Search Results

1

Efficacy of oral ondansetron, a selective antagonist of 5-HT3 receptors, in the treatment of nausea and vomiting associated with cyclophosphamide-based chemotherapies. Ondansetron Study Group.

Cubeddu LX, Pendergrass K, Ryan T, York M, Burton G, Meshad M, Galvin D, Ciociola AA. Cubeddu LX, et al. Am J Clin Oncol. 1994 Apr;17(2):137-46. doi: 10.1097/00000421-199404000-00010. Am J Clin Oncol. 1994. PMID: 8141105 Clinical Trial.

2

Ondansetron for nausea and vomiting associated with moderately emetogenic cancer chemotherapy.

DiBenedetto J Jr, Cubeddu LX, Ryan T, Kish JA, Sciortino D, Beall C, Eisenberg PD, Henderson C, Griffin D, Wentz A. DiBenedetto J Jr, et al. Among authors: cubeddu lx. Clin Ther. 1995 Nov-Dec;17(6):1091-8. doi: 10.1016/0149-2918(95)80087-5. Clin Ther. 1995. PMID: 8750400 Clinical Trial.

3

Antagonism of serotonin S3 receptors with ondansetron prevents nausea and emesis induced by cyclophosphamide-containing chemotherapy regimens.

Cubeddu LX, Hoffman IS, Fuenmayor NT, Finn AL. Cubeddu LX, et al. J Clin Oncol. 1990 Oct;8(10):1721-7. doi: 10.1200/JCO.1990.8.10.1721. J Clin Oncol. 1990. PMID: 2145400 Clinical Trial.

4

Participation of serotonin on early and delayed emesis induced by initial and subsequent cycles of cisplatinum-based chemotherapy: effects of antiemetics.

Cubeddu LX, Hoffmann IS. Cubeddu LX, et al. J Clin Pharmacol. 1993 Aug;33(8):691-7. doi: 10.1002/j.1552-4604.1993.tb05608.x. J Clin Pharmacol. 1993. PMID: 7691898

5

Ondansetron and metformin-induced gastrointestinal side effects.

Hoffmann IS, Roa M, Torrico F, Cubeddu LX. Hoffmann IS, et al. Among authors: cubeddu lx. Am J Ther. 2003 Nov-Dec;10(6):447-51. doi: 10.1097/00045391-200311000-00012. Am J Ther. 2003. PMID: 14624284 Clinical Trial.

6

Serotonin mechanisms in chemotherapy-induced emesis in cancer patients.

Cubeddu LX. Cubeddu LX. Oncology. 1996 Jun;53 Suppl 1:18-25. doi: 10.1159/000227636. Oncology. 1996. PMID: 8692546 Review.

7

Mechanisms by which cancer chemotherapeutic drugs induce emesis.

Cubeddu LX. Cubeddu LX. Semin Oncol. 1992 Dec;19(6 Suppl 15):2-13. Semin Oncol. 1992. PMID: 1485177 Review.

8

Plasma chromogranin A: a marker of serotonin release and of emesis associated with cisplatin chemotherapy.

Cubeddu LX, O'Connor DT, Parmer RJ. Cubeddu LX, et al. J Clin Oncol. 1995 Mar;13(3):681-7. doi: 10.1200/JCO.1995.13.3.681. J Clin Oncol. 1995. PMID: 7533826

9

Comparative efficacy of a single oral dose of ondansetron and of buspirone against cisplatin-induced emesis in cancer patients.

Alfieri AB, Cubeddu LX. Alfieri AB, et al. Among authors: cubeddu lx. Br J Cancer. 1995 Oct;72(4):1013-5. doi: 10.1038/bjc.1995.452. Br J Cancer. 1995. PMID: 7547213 Free PMC article. Clinical Trial.

10

Antiemetic activity of ondansetron in acute gastroenteritis.

Cubeddu LX, Trujillo LM, Talmaciu I, Gonzalez V, Guariguata J, Seijas J, Miller IA, Paska W. Cubeddu LX, et al. Aliment Pharmacol Ther. 1997 Feb;11(1):185-91. doi: 10.1046/j.1365-2036.1997.97269000.x. Aliment Pharmacol Ther. 1997. PMID: 9042992 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

164 results

Search Page

Filters